guajiguaji
Lv5
1106 积分
2022-01-22 加入
-
PROTAC-mediated activation, rather than degradation, of a nuclear receptor reveals complex ligand-receptor interaction network
1天前
已完结
-
Rapamycin-inspired macrocycles with new target specificity
1天前
已完结
-
Cinnamamide: An insight into the pharmacological advances and structure–activity relationships
5天前
已完结
-
Discovery and Characterization of (8S,9R)-5-Fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-2,7,8,9-tetrahydro-3H-pyrido[4,3,2-de]phthalazin-3-one (BMN 673, Talazoparib), a Novel, Highly Potent, and Orally Efficacious Poly(ADP-ribose) Polymerase-1/2 Inhibitor, as an Anticancer Agent
10天前
已完结
-
Discovery of a potent and subtype-selective TYK2 degrader based on an allosteric TYK2 inhibitor
20天前
已完结
-
Trends in covalent drug discovery: a 2020-23 patent landscape analysis focused on select covalent reacting groups (CRGs) found in fda-approved drugs
23天前
已完结
-
Structure Optimization of c-Jun N-terminal Kinase 1 Inhibitors for Treating Idiopathic Pulmonary Fibrosis
25天前
已完结
-
Polypharmacological Drug Design Guided by Integrating Phenotypic and Restricted Fragment Docking Strategies
25天前
已完结
-
Peptidomimetic Analogues Act as Effective Inhibitors against SARS-CoV-2 by Blocking the Function of Cathepsin L
25天前
已完结
-
RNA-Binding Small Molecules in Drug Discovery and Delivery: An Overview from Fundamentals
25天前
已完结